Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 5031

1.

Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates.

Simkins J, Abbo LM, Camargo JF, Rosa R, Morris MI.

Transplantation. 2016 Jul 12. [Epub ahead of print]

PMID:
27548035
2.

The BCGΔBCG1419c strain, which produces more pellicle in vitro, improves control of chronic tuberculosis in vivo.

Pedroza-Roldán C, Guapillo C, Barrios-Payán J, Mata-Espinosa D, Aceves-Sánchez MJ, Marquina-Castillo B, Hernández-Pando R, Flores-Valdez MA.

Vaccine. 2016 Aug 18. pii: S0264-410X(16)30707-1. doi: 10.1016/j.vaccine.2016.08.035. [Epub ahead of print]

PMID:
27546876
3.

Rifapentine for the treatment of latent tuberculosis.

Egelund EF, Peloquin CA.

Expert Rev Clin Pharmacol. 2016 Aug 22:1-9. [Epub ahead of print]

PMID:
27545595
4.

Safety of secukinumab in the treatment of psoriasis.

Blauvelt A.

Expert Opin Drug Saf. 2016 Aug 22:1-8. [Epub ahead of print]

PMID:
27545070
5.

The epidemiology of tuberculosis in health care workers in South Africa: a systematic review.

Grobler L, Mehtar S, Dheda K, Adams S, Babatunde S, van der Walt M, Osman M.

BMC Health Serv Res. 2016 Aug 20;16(1):416. doi: 10.1186/s12913-016-1601-5.

PMID:
27544429
Free PMC Article
6.
7.

Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining TB/HIV co-epidemic.

Kunkel A, Crawford FW, Shepherd J, Cohen T.

AIDS. 2016 Aug 17. [Epub ahead of print]

PMID:
27536981
8.

Immune activation by Mycobacterium tuberculosis in HIV-infected and -uninfected subjects.

Wyndham-Thomas C, Corbiere V, Selis E, Payen MC, Goffard JC, Van Vooren JP, Mascart F, Dirix V.

J Acquir Immune Defic Syndr. 2016 Aug 16. [Epub ahead of print]

PMID:
27532475
9.

[A SYSTEMATIC REVIEW ON THE PREVALENCE AND INCIDENCE OF LATENT TUBERCULOSIS INFECTION AMONG PRISON POPULATION].

Kawatsu L, Uchimura K, Izumi K, Ohkado A.

Kekkaku. 2016 Apr;91(4):457-64. Japanese.

PMID:
27530018
10.

[AN OUTBREAK OF PULMONARY TUBERCULOSIS DUE TO DEFINITE EXOGENOUS REINFECTION AMONG ELDERLY INDIVIDUALS IN WELFARE FACILITIES].

Iwamoto S, Yano S, Nishikawa E, Tada M, Kadowaki T, Kimura M, Kobayashi K, Ikeda T.

Kekkaku. 2016 Apr;91(4):451-5. Japanese.

PMID:
27530017
11.

Immunotherapy for tuberculosis: future prospects.

Abate G, Hoft DF.

Immunotargets Ther. 2016 Apr 20;5:37-45. doi: 10.2147/ITT.S81892. eCollection 2016. Review.

PMID:
27529060
Free PMC Article
12.

The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis.

Alsdurf H, Hill PC, Matteelli A, Getahun H, Menzies D.

Lancet Infect Dis. 2016 Aug 10. pii: S1473-3099(16)30216-X. doi: 10.1016/S1473-3099(16)30216-X. [Epub ahead of print]

PMID:
27522233
13.

Getting bang for buck in the latent tuberculosis care cascade.

Dheda K.

Lancet Infect Dis. 2016 Aug 10. pii: S1473-3099(16)30313-9. doi: 10.1016/S1473-3099(16)30313-9. [Epub ahead of print] No abstract available.

PMID:
27522231
14.

Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study.

Balkhy HH, El Beltagy K, El-Saed A, Aljasir B, Althaqafi A, Alothman AF, Alshalaan M, Al-Jahdali H.

Ann Thorac Med. 2016 Jul-Sep;11(3):197-201. doi: 10.4103/1817-1737.185759.

15.

Genetic polymorphisms of CCL2 associated with susceptibility to latent tuberculous infection in Thailand.

Nonghanphithak D, Reechaipichitkul W, Namwat W, Lulitanond V, Naranbhai V, Faksri K.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1242-8. doi: 10.5588/ijtld.16.0017.

PMID:
27510253
16.

Diversity of Human and Macaque Airway Immune Cells at Baseline and During Tuberculosis Infection.

Silver RF, Myers AJ B S, Jarvela J M S, Flynn J, Rutledge T B S, Bonfield T Ph D, Lin PL.

Am J Respir Cell Mol Biol. 2016 Aug 10. [Epub ahead of print]

PMID:
27509488
17.

Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices.

Dara M, Solovic I, Sotgiu G, D'Ambrosio L, Centis R, Tran R, Goletti D, Duarte R, Aliberti S, de Benedictis FM, Bothamley G, Schaberg T, Abubakar I, Teixeira V, Ward B, Gratziou C, Migliori GB.

Eur Respir J. 2016 Aug 4. pii: ERJ-00840-2016. doi: 10.1183/13993003.00840-2016. [Epub ahead of print]

PMID:
27492827
18.

Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection.

Horne DJ, Graustein AD, Shah JA, Peterson G, Savlov M, Steele S, Narita M, Hawn TR.

J Infect Dis. 2016 Aug 2. pii: jiw347. [Epub ahead of print]

PMID:
27485354
19.

Lesson of the month 2: Against all odds.

Schattner A.

Clin Med (Lond). 2016 Aug;16(4):394-5. doi: 10.7861/clinmedicine.16-4-394.

PMID:
27481390
20.

Immunological Evidence for the Role of Mycobacteria in Sarcoidosis: A Meta-Analysis.

Fang C, Huang H, Xu Z.

PLoS One. 2016 Aug 1;11(8):e0154716. doi: 10.1371/journal.pone.0154716. eCollection 2016.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk